Skip to content

Enhancing the quality of information-sharing in primary care for children with respiratory tract infections

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN46104365
Enrollment
600
Registered
2006-04-12
Start date
2005-10-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Tract Diseases Respiratory 1. Unspecified acute upper respiratory infection 2. Unspecified acute lower respiratory infection

Interventions

Intervention: use of a new 'interactive' leaflet on respiratory tract infections by general practitioners within the consultation, and then provided to parents as a take-home resource. Comparison: usu

Sponsors

Cardiff University (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Subjects aged 6 months to 14 years who have been ill for 7 days or less, and have been diagnosed by their GP as having acute respiratory tract infection. This will include children suspected of having both upper and lower respiratory tract infections, and viral or bacterial infections, and will include sore throat, otitis media and sinusitis.

Exclusion criteria

Exclusion criteria: 1. With suspected pneumonia 2. Who have been formally diagnosed with asthma or who are currently taking or in need of oral or inhaled steroids or inhaled bronchodilators 3. Judged to need immediate admittance to hospital or with serious/concerning features 4. With serious concomitant illness (i.e. malignancy, cystic fibrosis) 5. Whose carer is unable to comply with the study protocol 6. Who have been seen previously for this illness episode 7. Who have been previously recruited into the trial (each child can only be recruited into the trial once) 8. Have a sibling who has been recruited into the trial (each family can only be recruited into the trial once)

Design outcomes

Primary

MeasureTime frame
1. Re-consultation for same episode of illness 2. Antibiotic prescription for the presenting illness at any point in the 2 week follow-up period

Secondary

MeasureTime frame
No secondary outcome measures

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 5, 2026